Clarithromycin Versus Metronidazole in First-Line Helicobacter Pylori Triple Eradication Therapy Based on Resistance to Antimicrobial Agents: Meta-Analysis

Clicks: 215
ID: 112987
2020
Free PDF
Article Quality & Performance Metrics
Overall Quality Improving Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
Abstract
Overall eradication rates with PAC and PAM were equivalent worldwide. In low MNZ-resistance areas, PAM may be recommended as first-line therapy. However, the efficacy of PAC may be insufficient, irrespective of susceptibility to CAM.
Reference Key
m2020journalclarithromycin Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Murata M;Sugimoto M;Mizuno H;Kanno T;Satoh K;;
Journal journal of clinical medicine
Year 2020
DOI
DOI not found
URL
https://www.pubmed.gov/32079208/
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE pubmed abstract nih national institutes of health national library of medicine pmid:32079208 pmc7073899 doi:10.3390/jcm9020543 masaki murata mitsushige sugimoto kiichi satoh

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.